155 related articles for article (PubMed ID: 19298642)
1. Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
Arikan H; Koc M; Cakalagaoglu F; Tuglular S; Ozener C; Akoglu E
Nephrology (Carlton); 2009 Apr; 14(2):219-26. PubMed ID: 19298642
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
3. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
Matl I; Viklický O; Voska L; Lodererová A; Vítko S
Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
[TBL] [Abstract][Full Text] [Related]
4. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
[TBL] [Abstract][Full Text] [Related]
5. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9.
Gionanlis L; Alexopoulos E; Papagianni A; Leontsini M; Memmos D
Ren Fail; 2008; 30(2):239-46. PubMed ID: 18300128
[TBL] [Abstract][Full Text] [Related]
6. [Role of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schonlein purpura nephritis].
Zhang GP; Dang XQ; Yi ZW; He XJ; Zhang JJ; Wu XC; Mo SH
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):125-8. PubMed ID: 17448307
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
Taguchi T; Bohle A
Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
[TBL] [Abstract][Full Text] [Related]
8. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M
Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
[TBL] [Abstract][Full Text] [Related]
9. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2002; 53(3):155-62. PubMed ID: 12476618
[TBL] [Abstract][Full Text] [Related]
10. Involvement of transglutaminase-2 in pathological changes in renal disease.
Ikee R; Kobayashi S; Hemmi N; Saigusa T; Namikoshi T; Yamada M; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Nephron Clin Pract; 2007; 105(3):c139-46. PubMed ID: 17228174
[TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin in normal and diseased human kidneys.
Okada M; Takemura T; Murakami K; Hino S; Yoshioka K
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):213-9. PubMed ID: 8699611
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis.
Capuano A; Costanzi S; Peluso G; Zannoni G; Vellone VG; Gremese E; Zoli A; Scott C; Beltrami CA; Romano G; Ferraccioli G
Arthritis Rheum; 2006 Nov; 54(11):3633-9. PubMed ID: 17075808
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[TBL] [Abstract][Full Text] [Related]
14. The correlation between the clinical, laboratory and histopathological features of childhood membranoproliferative glomerulonephritis and response to treatment.
Yalçinkaya F; Ince E; Tümer N; Ekim M
Turk J Pediatr; 1992; 34(3):135-44. PubMed ID: 1485380
[TBL] [Abstract][Full Text] [Related]
15. [The morphological heterogeneity of mesangioproliferative glomerulonephritis].
Gasanov AB; Varshavskiĭ VA; Serov VV
Arkh Patol; 1990; 52(9):46-51. PubMed ID: 2270980
[TBL] [Abstract][Full Text] [Related]
16. Glomerular enlargement in the progression of mesangial proliferative glomerulonephritis.
Daimon S; Koni I
Clin Nephrol; 1998 Mar; 49(3):145-52. PubMed ID: 9543595
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1, TNF-alpha and cytochrome c in human astrocytic tumors: a short-term follow up and correlation with survival.
Mabrouk GM; Ali EM; El-Rehany MA; El-Samoly HM
Clin Biochem; 2007 Feb; 40(3-4):255-60. PubMed ID: 17070791
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of tenascin in mesangial proliferative (IgA-negative) glomerulonephritis.
Wagrowska-Danilewicz M; Danilewicz M
Acta Histochem; 1999 Jul; 101(3):351-9. PubMed ID: 10443297
[TBL] [Abstract][Full Text] [Related]
19. Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal.
Kazama I; Matsubara M; Ejima Y; Michimata M; Suzuki M; Miyama N; Sato A; Sato H; Ito S
Clin Exp Nephrol; 2005 Mar; 9(1):62-8. PubMed ID: 15830276
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis of chronic glomerulonephritis--study on renal survival ratio of mesangial proliferative glomerulonephritis and membranoproliferative glomerulonephritis].
Saito T; Sato H; Kinoshita Y; Seino J; Furuyama T; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):959-65. PubMed ID: 2263026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
